.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Predict branded drug patent expiration
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Chubb
Merck
Express Scripts
Covington
Moodys
Queensland Health
US Department of Justice
Cipla
McKesson
Argus Health

Generated: July 21, 2017

DrugPatentWatch Database Preview

CARISOPRODOL, ASPIRIN AND CODEINE PHOSPHATE Drug Profile

« Back to Dashboard

Which patents cover Carisoprodol, Aspirin And Codeine Phosphate, and when can generic versions of Carisoprodol, Aspirin And Codeine Phosphate launch?

Carisoprodol, Aspirin And Codeine Phosphate is a drug marketed by Sandoz, Ingenus Pharms Nj, and Oxford Pharms. and is included in three NDAs.

The generic ingredient in CARISOPRODOL, ASPIRIN AND CODEINE PHOSPHATE is aspirin; carisoprodol; codeine phosphate. There are twenty-one drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the aspirin; carisoprodol; codeine phosphate profile page.

Summary for Tradename: CARISOPRODOL, ASPIRIN AND CODEINE PHOSPHATE

Patents:0
Applicants:3
NDAs:3
Suppliers / Packagers: see list2
Clinical Trials: see list105,169
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:CARISOPRODOL, ASPIRIN AND CODEINE PHOSPHATE at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sandoz
CARISOPRODOL, ASPIRIN AND CODEINE PHOSPHATE
aspirin; carisoprodol; codeine phosphate
TABLET;ORAL040118-001Apr 16, 1996ABRXNoYes► Subscribe► Subscribe
Ingenus Pharms Nj
CARISOPRODOL, ASPIRIN AND CODEINE PHOSPHATE
aspirin; carisoprodol; codeine phosphate
TABLET;ORAL040860-001Jan 7, 2010ABRXNoNo► Subscribe► Subscribe
Oxford Pharms
CARISOPRODOL, ASPIRIN AND CODEINE PHOSPHATE
aspirin; carisoprodol; codeine phosphate
TABLET;ORAL040283-001Dec 29, 1998DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Daiichi Sankyo
Dow
Colorcon
Cantor Fitzgerald
AstraZeneca
Farmers Insurance
Healthtrust
US Army
US Department of Justice
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot